시장보고서
상품코드
1738264

세계의 외과수술 시뮬레이션 시장 : 시뮬레이션 유형, 기능, 전문 분야, 최종사용자, 지역별 기회 및 예측(2018-2032년)

Global Surgical Simulation Market Assessment, By Simulation Type, By Function, By Specialty, By End-user, By Region, Opportunities and Forecast, 2018-2032F

발행일: | 리서치사: Markets & Data | 페이지 정보: 영문 244 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

세계의 외과수술 시뮬레이션 시장 규모는 2025-2032년의 예측 기간 중 CAGR 10.93%로 성장하며, 2024년 4억 6,012만 달러에서 2032년에는 10억 5,503만 달러에 달할 것으로 예측됩니다.

이 시장의 성장은 의료 기술의 발전, 수술 훈련의 질적 향상을 통한 환자 결과 개선에 대한 관심 증가, 만성질환의 유병률 증가, 최소 침습 수술에 대한 선호도 증가에 힘입어 성장세를 보이고 있습니다. 또한 의료 실수 감소에 대한 관심이 높아지고 시뮬레이션 기반 학습이 의료 산업에 제공하는 다양한 이점에 대한 인식이 높아지면서 정부 기관과 의료 기관이 수술 시뮬레이션 솔루션에 대한 투자를 늘리고 있습니다.

양질의 치료 결과와 환자 안전에 대한 관심이 높아짐에 따라 수술 시뮬레이션 툴의 활용이 촉진되고 있습니다. 이러한 툴을 통해 의대생과 외과의사들은 수술 기술을 반복적으로 연습할 수 있으며, 수술 중 실수를 줄이고 정확성과 정밀도를 향상시킬 수 있습니다. 이러한 훈련 솔루션은 심장 수술, 외상 수술, 신경외과와 같은 복잡한 수술에 특히 유용합니다.

또한 몰입형 기술의 급속한 발전과 개별화된 피드백 및 실시간 성능 분석이 가능해짐에 따라 의료 종사자와 학생들이 자신의 기술을 향상시키고, 귀중한 피드백을 얻고, 의료 분야의 변화에 적응할 수 있게 되었습니다. 이에 따라 전 세계 주요 의료기기 제조업체들은 새로운 제품과 기술을 개발하기 위해 노력하고 있습니다. 예를 들어 2023년 11월 Smile Train Inc.의 한 부서인 Simulare Medical은 ABG(Arbeolar bone graft) 시술을 일련의 흐름으로 연습할 수 있는 ABG 시뮬레이터를 출시했습니다.

세계의 외과수술 시뮬레이션 시장을 조사했으며, 시장의 정의와 개요, 시장 규모 추이·예측, 각종 구분별 상세 분석, 산업 구조, 시장 성장에 대한 영향요인의 분석, 경쟁 구도, 주요 기업의 개요 등을 정리하여 전해드립니다.

목차

제1장 프로젝트 범위와 정의

제2장 조사 방법

제3장 미국 관세의 영향

제4장 개요

제5장 세계의 외과수술 시뮬레이션 시장 전망

  • 시장 규모 분석·예측
  • 시장 점유율 분석·예측
    • 시뮬레이션 유형별
      • 증강현실(AR)
      • 가상현실(VR)
      • 혼합현실(MR)
    • 기능별
      • 의료 연수
      • 의료기기 개발
    • 전문 분야별
      • 심장 수술
      • 소화기 내과
      • 신경외과
      • 정형외과
      • 재건 수술
      • 종양 외과
      • 이식
      • 기타
    • 최종사용자별
      • 병원·진료소
      • 학술연구기관
      • 외과 센터
      • 의료기기 기업
      • 기타
    • 지역별
      • 북미
      • 유럽
      • 아시아태평양
      • 남미
      • 중동 및 아프리카
    • 기업 점유율 분석(상위 5사 및 기타)
  • 시장 맵 분석

제6장 북미의 외과수술 시뮬레이션 시장 전망

  • 시장 규모 분석·예측
  • 시장 점유율 분석·예측
  • 국가별 시장 평가
    • 캐나다
    • 멕시코

제7장 유럽의 외과수술 시뮬레이션 시장 전망

  • 독일
  • 프랑스
  • 이탈리아
  • 영국
  • 러시아
  • 네덜란드
  • 스페인
  • 튀르키예
  • 폴란드

제8장 아시아태평양의 외과수술 시뮬레이션 시장 전망

  • 인도
  • 중국
  • 일본
  • 호주
  • 베트남
  • 한국
  • 인도네시아
  • 필리핀

제9장 남미의 외과수술 시뮬레이션 시장 전망

  • 브라질
  • 아르헨티나

제10장 중동 및 아프리카의 외과수술 시뮬레이션 시장 전망

  • 사우디아라비아
  • UAE
  • 남아프리카공화국

제11장 수급 분석

제12장 Porter's Five Forces 분석

제13장 PESTLE 분석

제14장 가격 분석

제15장 시장 역학

  • 시장 성장 촉진요인
  • 시장이 해결해야 할 과제

제16장 시장 동향·배포

제17장 규제 상황

제18장 기술의 진보와 혁신

제19장 사례 연구

제20장 경쟁 구도

  • 상위 5사의 경쟁 매트릭스
  • 상위 5사의 SWOT 분석
  • 상위 10사의 상황
    • MATERIALISE NV
    • Stratasys, Ltd.
    • Simulab Corporation
    • Laerdal Medical Corporation
    • Madison Industries Holdings LLC(CAE Healthcare, Inc.)
    • Kyoto Kagaku Co., Ltd.
    • Gaumard Scientific Company, Inc.
    • Surgical Science Sweden AB
    • VirtaMed AG
    • Mentice AB

제21장 전략적 제안

제22장 조사회사 소개·면책사항

KSA 25.06.18

Global surgical simulation market is projected to witness a CAGR of 10.93% during the forecast period 2025-2032, growing from USD 460.12 million in 2024 to USD 1055.03 million in 2032. The market's growth is supported by the rising advancements in medical technology, increasing focus on improving surgical training to enhance patient outcomes, growing prevalence of chronic diseases, and rising preference for minimally invasive procedures. The growing emphasis on reducing medical errors, along with the rising awareness about the various advantages associated with simulation-based learning in the healthcare industry, are further encouraging government organizations and medical institutions to increase their investments in surgical simulation solutions.

The rising emphasis on quality outcomes and patient safety is also propelling the utilization of surgical simulation tools as they enable medical students and surgeons to practice surgical procedures multiple times, reducing the chances of intraoperative mistakes and improving their accuracy and precision. These training solutions are particularly valuable in complex procedures, including cardiac procedures, trauma surgery, and neurosurgery.

Moreover, rapid advancements in immersive technologies, along with the availability of personalized feedback and real-time performance analytics, are aiding medical professionals and students in upgrading their skill sets and receiving valuable feedback, allowing them to adapt to the dynamic nature of the medical sector. Thus, leading medical device companies across the globe are working on introducing new products and technologies. For instance, in November 2023, Simulare Medical, a division of Smile Train Inc., launched the Alveolar Bone Graft (ABG) simulator that allows medical professionals to practice ABG procedures end-to-end.

Increasing Prevalence of Cancer Boosts Market Demand

The rising incidences of cancer across the globe are augmenting the reliance on complex surgical procedures, which in turn is propelling the demand for advanced training tools, including surgical simulation devices. The American Cancer Association estimates that over 2 million new cancer cases will be reported in the United States in 2025. Surgical simulation solutions provide surgeons with realistic and risk-free environments to master and practice surgical procedures, improving patient outcomes and the surgical skills of medical professionals. Three-dimensional simulation and virtual reality are extremely valuable in oncology as they allow surgeons to understand anatomical relationships, optimize operative planning, and rehearse tumor resection. Thus, various oncology professionals are using surgical simulation devices to enhance and upgrade their surgical skills.

Rising Investments Support Market Expansion

The rise in investments in surgical simulation companies and startups to bolster product development and the availability of technologically advanced solutions is one of the major drivers of the market. Increasing investments from private investors, government organizations, and healthcare companies enable the development of high-fidelity simulators that incorporate artificial intelligence, augmented reality, virtual reality, mixed reality, and haptic feedback, making surgical training more effective and immersive. Such investments also propel the creation of specialized simulators for minimally invasive and robotic surgeries, addressing the rising requirement for advanced training for complex procedures. For instance, in August 2024, Maximum Fidelity Surgical Simulations LLC received seed funding of USD 2.25 million to establish a new surgical simulation center. The facility aims to advance surgical education by providing a high-fidelity simulation environment to train medical professionals in minimally invasive and complex surgical procedures. By fostering collaboration and innovation among medical professionals, technology developers, and educators, the simulation center will play a crucial role in ensuring the availability of high-quality surgical training.

Medical Training Accounts for Significant Share of the Market

Simulation-based training aids in providing medical professionals with realistic environments to practice different surgical procedures, improving clinical competence and reducing the occurrence of medical errors. The growing preference for minimally invasive surgical procedures and the rising requirement for complex surgical procedures are further propelling the demand for advanced training tools among medical professionals. Additionally, the growing shortage of skilled surgeons in different regions across the globe is further propelling the demand for effective simulation-based tools to bridge the training gaps and ensure that the patient population is provided with high-quality care. Thus, leading educational institutions are focusing on providing surgical training with the help of surgical simulation technologies. For instance, in September 2024, the newly renovated nurse anesthesia surgical simulation room was unveiled, which includes modern infrastructure such as an operating room sink, additional outlets, and a one-way mirror for instructor observation during simulations. While primarily designed for the nurse anesthesia program, the facility is accessible to other university programs, broadening its impact.

North America Holds Major Market Share

The market's expansion in the region can be attributed to the high emphasis on research and development activities in countries such as the United States and Canada, the adoption of high-end technological solutions, and the presence of a well-established healthcare infrastructure. The rise in strategic collaborations among medical device companies and academic institutions, coupled with the strong presence of leading simulation technology providers in the region, further supports the market's expansion. The market also benefits from the strong funding available for healthcare education and innovation in the region, allowing surgical simulation integration in residency programs. Furthermore, leading surgical simulation providers are also working on introducing new products and technologies in the United States, propelling the market's growth. For instance, in February 2023, Marion Surgical Limited was issued a patent in the United States that covered the Marion System, a tool with haptic feedback assembly that provides advanced surgical training.

Impact of the U.S. Tariffs on Global Surgical Simulation Market

Different surgical simulation systems rely on highly specialized components such as sensors and high-resolution displays, many of which are sourced from China. The cost of such essential components is impacted due to the 25% tariffs on aluminum and steel-containing products. Consequently, medical device manufacturers are witnessing increased production costs, which may be passed on to the end-users, including training institutions and hospitals, which may limit access to advanced medical solutions, including surgical simulation devices.

The tariffs are also disrupting supply chains, resulting in delays in procuring critical components for surgical simulation devices. Healthcare professionals are experiencing delays in training and potential compromises in surgical preparedness due to the unavailability of essential equipment.

Key Players Landscape and Outlook

The leading market players are focusing on technological innovations to address the rising requirements for economically efficient anatomical models in different regions across the globe. For instance, in June 2024, Stratasys, Ltd. launched the J5 Digital Anatomy 3D printer, designed to meet the growing demand for high-fidelity anatomical models. The printer is designed to enable research institutions, hospitals, and medical device manufacturers to improve treatment outcomes and support the availability of novel solutions by streamlining operations. By facilitating the availability of precise, repeatable, and affordable surgical simulations, the key players of the market are accelerating the development of new medical devices and bolstering the accessibility of high-quality training solutions for medical professionals.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Impact of the U.S. Tariffs

4. Executive Summary

5. Global Surgical Simulation Market Outlook, 2018-2032F

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share Analysis & Forecast
    • 5.2.1. By Simulation Type
      • 5.2.1.1. Augmented Reality
      • 5.2.1.2. Virtual Reality
      • 5.2.1.3. Mixed Reality
    • 5.2.2. By Function
      • 5.2.2.1. Medical Training
      • 5.2.2.2. Medical Device Development
    • 5.2.3. By Specialty
      • 5.2.3.1. Cardiac Surgery
      • 5.2.3.2. Gastroenterology
      • 5.2.3.3. Neurosurgery
      • 5.2.3.4. Orthopedic Surgery
      • 5.2.3.5. Reconstructive Surgery
      • 5.2.3.6. Oncology Surgery
      • 5.2.3.7. Transplants
      • 5.2.3.8. Others
    • 5.2.4. By End-user
      • 5.2.4.1. Hospitals and Clinics
      • 5.2.4.2. Academic and Research Institutions
      • 5.2.4.3. Surgical Centers
      • 5.2.4.4. Medical Device Companies
      • 5.2.4.5. Others
    • 5.2.5. By Region
      • 5.2.5.1. North America
      • 5.2.5.2. Europe
      • 5.2.5.3. Asia-Pacific
      • 5.2.5.4. South America
      • 5.2.5.5. Middle East and Africa
    • 5.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
  • 5.3. Market Map Analysis, 2024
    • 5.3.1. By Simulation Type
    • 5.3.2. By Function
    • 5.3.3. By Specialty
    • 5.3.4. By End-user
    • 5.3.5. By Region

6. North America Surgical Simulation Market Outlook, 2018-2032F

  • 6.1. Market Size Analysis & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share Analysis & Forecast
    • 6.2.1. By Simulation Type
      • 6.2.1.1. Augmented Reality
      • 6.2.1.2. Virtual Reality
      • 6.2.1.3. Mixed Reality
    • 6.2.2. By Function
      • 6.2.2.1. Medical Training
      • 6.2.2.2. Medical Device Development
    • 6.2.3. By Specialty
      • 6.2.3.1. Cardiac Surgery
      • 6.2.3.2. Gastroenterology
      • 6.2.3.3. Neurosurgery
      • 6.2.3.4. Orthopedic Surgery
      • 6.2.3.5. Reconstructive Surgery
      • 6.2.3.6. Oncology Surgery
      • 6.2.3.7. Transplants
      • 6.2.3.8. Others
    • 6.2.4. By End-user
      • 6.2.4.1. Hospitals and Clinics
      • 6.2.4.2. Academic and Research Institutions
      • 6.2.4.3. Surgical Centers
      • 6.2.4.4. Medical Device Companies
      • 6.2.4.5. Others
    • 6.2.5. By Country Share
      • 6.2.5.1. United States
      • 6.2.5.2. Canada
      • 6.2.5.3. Mexico
  • 6.3. Country Market Assessment
    • 6.3.1. United States Surgical Simulation Market Outlook, 2018-2032F*
      • 6.3.1.1. Market Size Analysis & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share Analysis & Forecast
        • 6.3.1.2.1. By Simulation Type
          • 6.3.1.2.1.1. Augmented Reality
          • 6.3.1.2.1.2. Virtual Reality
          • 6.3.1.2.1.3. Mixed Reality
        • 6.3.1.2.2. By Function
          • 6.3.1.2.2.1. Medical Training
          • 6.3.1.2.2.2. Medical Device Development
        • 6.3.1.2.3. By Specialty
          • 6.3.1.2.3.1. Cardiac Surgery
          • 6.3.1.2.3.2. Gastroenterology
          • 6.3.1.2.3.3. Neurosurgery
          • 6.3.1.2.3.4. Orthopedic Surgery
          • 6.3.1.2.3.5. Reconstructive Surgery
          • 6.3.1.2.3.6. Oncology Surgery
          • 6.3.1.2.3.7. Transplants
          • 6.3.1.2.3.8. Others
        • 6.3.1.2.4. By End-user
          • 6.3.1.2.4.1. Hospitals and Clinics
          • 6.3.1.2.4.2. Academic and Research Institutions
          • 6.3.1.2.4.3. Surgical Centers
          • 6.3.1.2.4.4. Medical Device Companies
          • 6.3.1.2.4.5. Others
    • 6.3.2. Canada
    • 6.3.3. Mexico

All segments will be provided for all regions and countries covered

7. Europe Surgical Simulation Market Outlook, 2018-2032F

  • 7.1. Germany
  • 7.2. France
  • 7.3. Italy
  • 7.4. United Kingdom
  • 7.5. Russia
  • 7.6. Netherlands
  • 7.7. Spain
  • 7.8. Turkey
  • 7.9. Poland

8. Asia-Pacific Surgical Simulation Market Outlook, 2018-2032F

  • 8.1. India
  • 8.2. China
  • 8.3. Japan
  • 8.4. Australia
  • 8.5. Vietnam
  • 8.6. South Korea
  • 8.7. Indonesia
  • 8.8. Philippines

9. South America Surgical Simulation Market Outlook, 2018-2032F

  • 9.1. Brazil
  • 9.2. Argentina

10. Middle East and Africa Surgical Simulation Market Outlook, 2018-2032F

  • 10.1. Saudi Arabia
  • 10.2. UAE
  • 10.3. South Africa

11. Demand Supply Analysis

12. Porter's Five Forces Analysis

13. PESTLE Analysis

14. Pricing Analysis

15. Market Dynamics

  • 15.1. Market Drivers
  • 15.2. Market Challenges

16. Market Trends and Developments

17. Regulatory Landscape

18. Technological Advancements and Innovations

19. Case Studies

20. Competitive Landscape

  • 20.1. Competition Matrix of Top 5 Market Leaders
  • 20.2. SWOT Analysis for Top 5 Players
  • 20.3. Key Players Landscape for Top 10 Market Players
    • 20.3.1. MATERIALISE NV
      • 20.3.1.1. Company Details
      • 20.3.1.2. Key Management Personnel
      • 20.3.1.3. Products and Services
      • 20.3.1.4. Financials (As Reported)
      • 20.3.1.5. Key Market Focus and Geographical Presence
      • 20.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
    • 20.3.2. Stratasys, Ltd.
    • 20.3.3. Simulab Corporation
    • 20.3.4. Laerdal Medical Corporation
    • 20.3.5. Madison Industries Holdings LLC (CAE Healthcare, Inc.)
    • 20.3.6. Kyoto Kagaku Co., Ltd.
    • 20.3.7. Gaumard Scientific Company, Inc.
    • 20.3.8. Surgical Science Sweden AB
    • 20.3.9. VirtaMed AG
    • 20.3.10. Mentice AB

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

21. Strategic Recommendations

22. About Us and Disclaimer

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제